{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:36:00Z","timestamp":1774935360833,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaacapopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAACAP Open"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jaacop.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T04:10:25Z","timestamp":1705637425000},"page":"114-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stimulant Medication Shortens the Duration of Impairing Emotional Outbursts"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6178-6815","authenticated-orcid":false,"given":"Lauren M.","family":"Spring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8944-3566","authenticated-orcid":false,"given":"Joseph E.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6087-324X","authenticated-orcid":false,"given":"Gabrielle A.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaacop.2024.01.002_bib1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1176\/appi.ajp.160.3.430","article-title":"Defining clinical phenotypes of juvenile mania","volume":"160","author":"Leibenluft","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.jaacop.2024.01.002_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tics.2017.02.002","article-title":"Pediatric irritability: a systems neuroscience approach","volume":"21","author":"Leibenluft","year":"2017","journal-title":"Trends Cogn Sci"},{"issue":"2","key":"10.1016\/j.jaacop.2024.01.002_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaac.2022.03.014","article-title":"Narrative review: impairing emotional outbursts: what they are and what we should do about them","volume":"62","author":"Carlson","year":"2023","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"10.1016\/j.jaacop.2024.01.002_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jaac.2015.05.008","article-title":"Normative irritability in youth: developmental findings from the Great Smoky Mountains Study","volume":"54","author":"Copeland","year":"2015","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.jaacop.2024.01.002_bib5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1176\/appi.ps.202200028","article-title":"Factors associated with police bringing children to a psychiatric emergency room","volume":"74","author":"Farquharson","year":"2023","journal-title":"Psychiatr Serv"},{"issue":"2","key":"10.1016\/j.jaacop.2024.01.002_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.chc.2020.10.003","article-title":"The phenomenology of outbursts","volume":"30","author":"Spring","year":"2021","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"4","key":"10.1016\/j.jaacop.2024.01.002_bib7","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10578-021-01301-8","article-title":"Is Irritability a Top Problem in Youth Mental Health Care? A Multi-informant, Multi-method Investigation","volume":"54","author":"Evans","year":"2023","journal-title":"Child Psychiatry Hum Dev"},{"issue":"3","key":"10.1016\/j.jaacop.2024.01.002_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/cap.2008.0108","article-title":"Rages\u2014what are they and who has them?","volume":"19","author":"Carlson","year":"2009","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"2","key":"10.1016\/j.jaacop.2024.01.002_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.chc.2020.10.005","article-title":"Attention-deficit hyperactivity disorder and the dysregulation of emotion generation and emotional expression","volume":"30","author":"Blader","year":"2021","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"2","key":"10.1016\/j.jaacop.2024.01.002_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/jcpp.12899","article-title":"Practitioner review: emotional dysregulation in attention-deficit\/hyperactivity disorder\u2014implications for clinical recognition and intervention","volume":"60","author":"Faraone","year":"2019","journal-title":"J\u00a0Child Psychol Psychiatry"},{"issue":"3","key":"10.1016\/j.jaacop.2024.01.002_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1176\/appi.ajp.2013.13070966","article-title":"Emotion dysregulation in attention deficit hyperactivity disorder","volume":"171","author":"Shaw","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.jaacop.2024.01.002_bib12","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.jaac.2020.11.022","article-title":"Phasic vs tonic irritability: differential associations with attention-deficit\/hyperactivity disorder symptoms","volume":"60","author":"Cardinale","year":"2021","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaacop.2024.01.002_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jad.2017.03.050","article-title":"Irritability in ADHD: associations with depression liability","volume":"215","author":"Eyre","year":"2017","journal-title":"J\u00a0Affect Disord"},{"issue":"8","key":"10.1016\/j.jaacop.2024.01.002_bib14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1089\/cap.2019.0039","article-title":"Maladaptive aggression: with a focus on impulsive aggression in children and adolescents","volume":"29","author":"Connor","year":"2019","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"3","key":"10.1016\/j.jaacop.2024.01.002_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/chi.0b013e31802f1454","article-title":"Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies","volume":"46","author":"Jensen","year":"2007","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.jaacop.2024.01.002_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/070674371506000202","volume":"60","author":"Pringsheim","year":"2015","journal-title":"Can J Psychiatry"},{"issue":"3","key":"10.1016\/j.jaacop.2024.01.002_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00004583-200203000-00004","article-title":"Psychopharmacology and aggression. I: a meta-analysis of stimulant effects on overt\/covert aggression-related behaviors in ADHD","volume":"41","author":"Connor","year":"2002","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.jaacop.2024.01.002_bib18","first-page":"27","article-title":"Pharmacotherapy of aggression in children and adolescents: efficacy and effect size","volume":"15","author":"Pappadopulos","year":"2006","journal-title":"J\u00a0Can Acad Child Adolesc Psychiatry"},{"issue":"7","key":"10.1016\/j.jaacop.2024.01.002_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180355","article-title":"The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials","volume":"12","author":"Catala-Lopez","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jaacop.2024.01.002_bib20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.jaacop.2024.01.002_bib21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.chc.2022.02.003","article-title":"Updates in pharmacologic strategies for emotional dysregulation in attention deficit hyperactivity disorder","volume":"31","author":"Baweja","year":"2022","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"3","key":"10.1016\/j.jaacop.2024.01.002_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaac.2022.05.012","article-title":"Systematic review and meta-analysis: pharmacological and nonpharmacological interventions for persistent nonepisodic irritability","volume":"62","author":"Breaux","year":"2023","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.jaacop.2024.01.002_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaac.2014.10.006","article-title":"Treatment of children with attention-deficit\/hyperactivity disorder (ADHD) and irritability: results from the Multimodal Treatment Study of Children with ADHD (MTA)","volume":"54","author":"Fernandez de la Cruz","year":"2015","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.jaacop.2024.01.002_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/104454603322163844","article-title":"Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder titration trial","volume":"13","author":"Galanter","year":"2003","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"5-6","key":"10.1016\/j.jaacop.2024.01.002_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cnr.2005.09.008","article-title":"ADHD and manic symptoms: diagnostic and treatment implications","volume":"5","author":"Galanter","year":"2005","journal-title":"Clin Neurosci Res"},{"issue":"3","key":"10.1016\/j.jaacop.2024.01.002_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1037\/a0019699","article-title":"Assessment of dysregulated children using the Child Behavior Checklist: a receiver operating characteristic curve analysis","volume":"22","author":"Althoff","year":"2010","journal-title":"Psychol Assess"},{"issue":"6","key":"10.1016\/j.jaacop.2024.01.002_bib27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/cap.2008.065","article-title":"The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit\/hyperactivity disorder and severe mood dysregulation","volume":"18","author":"Waxmonsky","year":"2008","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"3","key":"10.1016\/j.jaacop.2024.01.002_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jaac.2015.12.011","article-title":"A\u00a0randomized clinical trial of an integrative group therapy for children with severe mood dysregulation","volume":"55","author":"Waxmonsky","year":"2016","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.jaacop.2024.01.002_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaac.2013.09.022","article-title":"What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit\/hyperactivity disorder?","volume":"53","author":"Aman","year":"2014","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.jaacop.2024.01.002_bib30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaac.2019.12.009","article-title":"Stepped treatment for attention-deficit\/hyperactivity disorder and aggressive behavior: a randomized, controlled trial of adjunctive risperidone, divalproex sodium, or placebo after stimulant medication optimization","volume":"60","author":"Blader","year":"2021","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"9","key":"10.1016\/j.jaacop.2024.01.002_bib31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jaac.2014.05.008","article-title":"Risperidone added to parent training and stimulant medication: effects on attention-deficit\/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression","volume":"53","author":"Gadow","year":"2014","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"10.1016\/j.jaacop.2024.01.002_bib32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s40263-015-0264-9","article-title":"Emotional lability in patients with attention-deficit\/hyperactivity disorder: impact of pharmacotherapy","volume":"29","author":"Childress","year":"2015","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.jaacop.2024.01.002_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaac.2021.09.415","article-title":"Does pro re nata oral medication shorten outburst duration in children?","volume":"61","author":"Carlson","year":"2022","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaacop.2024.01.002_bib34","series-title":"Kaufman Test of Educational Achievement","author":"Kaufman","year":"2014"},{"issue":"2","key":"10.1016\/j.jaacop.2024.01.002_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-3956(01)00052-8","article-title":"Validation of the Behavioural Activity Rating Scale (BARS): a novel measure of activity in agitated patients","volume":"36","author":"Swift","year":"2002","journal-title":"J\u00a0Psychiatr Res"},{"issue":"4","key":"10.1016\/j.jaacop.2024.01.002_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/cap.2007.5124","article-title":"A\u00a0retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed","volume":"17","author":"Barzman","year":"2007","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"1","key":"10.1016\/j.jaacop.2024.01.002_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1753-2000-3-9","article-title":"Conventional intramuscular sedatives vs ziprasidone for severe agitation in adolescents: case-control study","volume":"3","author":"Jangro","year":"2009","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"6","key":"10.1016\/j.jaacop.2024.01.002_bib38","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1517\/14656566.6.6.1003","article-title":"Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD","volume":"6","author":"Weisler","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl 1","key":"10.1016\/j.jaacop.2024.01.002_bib39","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr Bull"},{"issue":"11","key":"10.1016\/j.jaacop.2024.01.002_bib40","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s40263-014-0175-1","article-title":"A\u00a0review of OROS methylphenidate (Concerta((R))) in the treatment of attention-deficit\/hyperactivity disorder","volume":"28","author":"Katzman","year":"2014","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.jaacop.2024.01.002_bib41","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.1542\/peds.107.6.e105","article-title":"Once-a-day Concerta methylphenidate vs three-times-daily methylphenidate in laboratory and natural settings","volume":"107","author":"Pelham","year":"2001","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.jaacop.2024.01.002_bib42","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1542\/peds.103.4.e43","article-title":"A\u00a0comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit\/hyperactivity disorder","volume":"103","author":"Pelham","year":"1999","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.jaacop.2024.01.002_bib43","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","article-title":"A\u00a014-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD","volume":"56","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaacop.2024.01.002_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/207801","article-title":"Methylphenidate efficacy: immediate vs extended release at short term in Mexican Children with ADHD assessed by Conners scale and EEG","volume":"2015","author":"Durand-Rivera","year":"2015","journal-title":"Neurol Res Int"},{"issue":"8","key":"10.1016\/j.jaacop.2024.01.002_bib45","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00787-006-0549-0","article-title":"Long-acting medications for the hyperkinetic disorders. a systematic review and European treatment guideline","volume":"15","author":"Banaschewski","year":"2006","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.jaacop.2024.01.002_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1399-5618.2010.00793.x","article-title":"Liquid risperidone in the treatment of rages in psychiatrically hospitalized children with possible bipolar disorder","volume":"12","author":"Carlson","year":"2010","journal-title":"Bipolar Disord"},{"issue":"2","key":"10.1016\/j.jaacop.2024.01.002_bib47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"issue":"5","key":"10.1016\/j.jaacop.2024.01.002_bib48","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1399-5618.2012.01029.x","article-title":"Will disruptive mood dysregulation disorder reduce false diagnosis of bipolar disorder in children?","volume":"14","author":"Margulies","year":"2012","journal-title":"Bipolar Disord"},{"issue":"2","key":"10.1016\/j.jaacop.2024.01.002_bib49","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1037\/pas0000664","article-title":"Do we need an irritable subtype of ADHD? Replication and extension of a promising temperament profile approach to ADHD subtyping","volume":"31","author":"Karalunas","year":"2019","journal-title":"Psychol Assess"},{"issue":"1","key":"10.1016\/j.jaacop.2024.01.002_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10567-022-00422-3","article-title":"Finding a needed diagnostic home for children with impulsive aggression","volume":"26","author":"Stepanova","year":"2023","journal-title":"Clin Child Fam Psychol Rev"}],"container-title":["JAACAP Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949732924000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949732924000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T01:08:26Z","timestamp":1740704906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949732924000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2949732924000036"],"URL":"https:\/\/doi.org\/10.1016\/j.jaacop.2024.01.002","relation":{},"ISSN":["2949-7329"],"issn-type":[{"value":"2949-7329","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stimulant Medication Shortens the Duration of Impairing Emotional Outbursts","name":"articletitle","label":"Article Title"},{"value":"JAACAP Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaacop.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Academy of Child & Adolescent Psychiatry.","name":"copyright","label":"Copyright"}]}}